Earnings Call · Q4 FY2024·2025-02-27

Q4 24EPS +18.42%·Rev n/aQ3 24EPS -30.77%·Rev n/aQ2 24EPS +7.14%·Rev n/aQ1 24EPS +12.50%·Rev n/a⚠ consensus missing

AbCellera Biologics Inc. ABCL

Tryn Stimart — Chief Legal and Compliance Officer

Carl Hansen — President and CEO

Andrew Booth — Chief Financial Officer

0.0%1d on move date+1.6% vs SPY3d−19.2%5d−18.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABCL calls or request research access.

More ABCL calls Browse calls Request research access